Asset Management Investors »

4d Molecular Therapeutics In shares owned by Asset Management Investors

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Asset Management Investors from 13F filings

Historical chart of Asset Management Investors investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Asset Management Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Asset Management Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $174k 20k 8.69
2025-06-30 $74k 20k 3.71
2025-03-31 $65k 20k 3.23
2024-12-31 $119k 20k 5.93